Webinar: BCBS Plans and Civica Rx Partner to Produce Lower-Cost Generic Drugs – Opportunities for States
The nonprofit Civica Rx launched in 2018 to combat drug shortages and price spikes in hospitals. As COVID- 19 brings concern about additional drug shortages, the idea of producing more and less costly generic drugs takes on even more urgency. Recently, the Blue Cross Blue Shield Association (BCBS) and 18 of its plans announced a partnership with Civica Rx and its manufacturing partners to produce lower cost generic drugs. The collaboration aims to bring more affordable generics to uncompetitive markets in exchange for aggregated volume and multi-year purchasing commitments.
The goal is also to achieve meaningful savings for individuals and families by early 2022. The partnership is inviting other health plans to join the initiative, opening the door for state public purchasers to participate.
Learn more about this creative partnership and opportunities for states during this webinar, which features:
Moderator:
Trish Riley, NASHP Executive Director
Speakers:
Andy Chasen, Vice President of Federal Policy and Advocacy, Blue Shield of California
Jennifer Spalding, General Counsel and Chief Operating Officer, Civica Rx
Thursday, April 2, 2020
1-2:15 p.m. (ET)




For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































